Photo for representational purpose only. Reuters file
December 23
A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.
After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus’s Delta variant after two doses, the company added.
The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca. Reuters
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Swati Maliwal case: Bibhav Kumar formatted iPhone, CCTV footage of ‘assault’ incident blank, Delhi Police tell court
'Assault could have been fatal’, say police in its remand ap...
Police seized CCTV DVR from Kejriwal’s house, planting stories to tarnish party’s image: AAP
There was no immediate reaction from the Delhi police
'Had Sisodia been here, things wouldn't have been so bad for me', says AAP Rajya Sabha MP Swati Maliwal
'Party leaders once sought justice for Nirbhaya, today they ...
Arrest warrant against JD(S) MP Prajwal Revanna in sexual assault case
NDA’s Hassan Lok Sabha candidate is at large
Pune luxury car accident: Father of teen, bar that served him liquor to be booked, say police
2 people were killed when the speeding luxury car hit their ...
